Literature DB >> 21521263

The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.

Anand Vaidya1, Bei Sun, John P Forman, Paul N Hopkins, Nancy J Brown, Nikheel S Kolatkar, Gordon H Williams, Jonathan S Williams.   

Abstract

OBJECTIVES: 25-Hydroxyvitamin D (25(OH)D) deficiency and excess activity of the renin-angiotensin system (RAS) are both associated with cardiovascular disease. Vitamin D interacts with the vitamin D receptor (VDR) to negatively regulate renin expression in mice; however, human studies linking genetic variation in the VDR with renin are lacking. We evaluated (i) whether genetic variation in the VDR at the Fok1 polymorphism was associated with plasma renin activity (PRA) in a population of hypertensives and a separate population of normotensives and (ii) whether the association between Fok1 genotype and PRA was independent of 25(OH)D levels. DESIGN/PATIENTS/MEASUREMENTS: Genetic association study, assuming an additive model of inheritance, of 375 hypertensive and 146 normotensive individuals from the HyperPATH cohort, who had PRA assessments after 1 week of high dietary sodium balance (HS) and l week of low dietary sodium balance (LS).
RESULTS: The minor allele (T) at the Fok1 polymorphism was significantly associated with lower PRA in hypertensives (LS: β = -0·22, P < 0·01; HS: β = -0·19, P < 0·01); when repeated in normotensives, a similar relationship was observed (LS: β = -0·17, P < 0·05; HS: β = -0·18, P = 0·14). In multivariable analyses, both higher 25(OH)D levels and the T allele at Fok1 were independently associated with lower PRA in hypertensives; however, 25(OH)D was not associated with PRA in normotensives.
CONCLUSIONS: Genetic variation at the Fok1 polymorphism of the VDR gene, in combination with 25(OH)D levels, was associated with PRA in hypertension. These findings support the vitamin D-VDR complex as a potential regulator of renin activity in humans.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521263      PMCID: PMC3089671          DOI: 10.1111/j.1365-2265.2011.03991.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  36 in total

Review 1.  Molecular epidemiology of vitamin D receptor gene variants.

Authors:  J M Zmuda; J A Cauley; R E Ferrell
Journal:  Epidemiol Rev       Date:  2000       Impact factor: 6.222

2.  Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt.

Authors:  Deborah A Price; Naomi D L Fisher; M Cecilia Lansang; Radomir Stevanovic; Gordon H Williams; Norman K Hollenberg
Journal:  Hypertension       Date:  2002-08       Impact factor: 10.190

3.  Aldosterone--villain or bystander?

Authors:  Robert G Dluhy; Gordon H Williams
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

4.  The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.

Authors:  P W Jurutka; L S Remus; G K Whitfield; P D Thompson; J C Hsieh; H Zitzer; P Tavakkoli; M A Galligan; H T Dang; C A Haussler; M R Haussler
Journal:  Mol Endocrinol       Date:  2000-03

5.  Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension.

Authors:  Paul N Hopkins; Steven C Hunt; Xavier Jeunemaitre; Barbara Smith; Daniel Solorio; Naomi D L Fisher; Norman K Hollenberg; Gordon H Williams
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

6.  Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3.

Authors:  E M Colin; A E Weel; A G Uitterlinden; C J Buurman; J C Birkenhäger; H A Pols; J P van Leeuwen
Journal:  Clin Endocrinol (Oxf)       Date:  2000-02       Impact factor: 3.478

7.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  Calcium metabolism in essential hypertension: relationship to altered renin system activity.

Authors:  L M Resnick; J P Nicholson; J H Laragh
Journal:  Fed Proc       Date:  1986-11

9.  Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism.

Authors:  L M Resnick; F B Müller; J H Laragh
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

Review 10.  Genetics and biology of vitamin D receptor polymorphisms.

Authors:  André G Uitterlinden; Yue Fang; Joyce B J Van Meurs; Huibert A P Pols; Johannes P T M Van Leeuwen
Journal:  Gene       Date:  2004-09-01       Impact factor: 3.688

View more
  31 in total

1.  Meta-Analysis of the Association Between the rs228570 Vitamin D Receptor Gene Polymorphism and Arterial Hypertension Risk.

Authors:  Ivone F O C Nunes; Ana A C M Cavalcante; Marcus V O B Alencar; Marcos D F Carvalho; José L R Sarmento; Nayra S C C A Teixeira; Adriana A Paiva; Lídia R Carvalho; Leopoldo F M Nascimento; Maria S P Cruz; Marcelo M Rogero; Andréia C B Lima; Cecilia M R G Carvalho
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

Review 2.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

3.  Vitamin D and insulin sensitivity: can gene association and pharmacogenetic studies of the vitamin D receptor provide clarity?

Authors:  Anand Vaidya; Jonathan S Williams
Journal:  Metabolism       Date:  2012-02-02       Impact factor: 8.694

Review 4.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

5.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

Review 6.  Role of Vitamin D in Cardiovascular Diseases.

Authors:  Vikrant Rai; Devendra K Agrawal
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

Review 7.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

8.  Vitamin D and Major Chronic Illness.

Authors:  Sadeq A Quraishi; Carlos A Camargo
Journal:  J Restor Med       Date:  2012-09

9.  Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure.

Authors:  Michael P Dorsch; Carrie W Nemerovski; Vicki L Ellingrod; Jennifer A Cowger; D Bradley Dyke; Todd M Koelling; Audrey H Wu; Keith D Aaronson; Robert U Simpson; Barry E Bleske
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-02-04       Impact factor: 2.457

10.  Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.

Authors:  Q Cheng; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2012-12-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.